-transparent.png){kind=logo}
The proliferative T lymphocyte responses to two different mumps antigen preparations, S (nucleocapsid) and V (viral envelope), were characterized. Eight patients with Type 1 (insulin-dependent) diabetes mellitus were all found to be responders to S and V mumps antigen. Among the 64 healthy individuals, 52 were classified as responders to the S antigen and 50 responders to the V antigen. No difference was found between T lymphocytes from Type 1 diabetic patients and those from healthy individuals as regards the effect of indomethacin on the mumps-specific response. The majority of the mumps-specific T lymphocytes seemed to be restricted by epitopes on the HLA-DR molecules. The frequency of mumps antigen-reactive T lymphocytes (ARTL) was found to be low when the response was restricted by DR3-associated elements, and high when it was restricted by DR4-associated elements, compared to the frequency of ARTL when other DR-associated elements restricted the mumps-specific response. For the majority of the individuals tested, the DR-associated hypo- and hyper-responsiveness was found with both the S and the V mumps antigens.
O Bruserud, and
E Thorsby
March 1999,
Journal of autoimmunity,
O Bruserud, and
E Thorsby
September 2006,
Journal of hypertension,
O Bruserud, and
E Thorsby
September 2016,
Diabetologia,
O Bruserud, and
E Thorsby
January 1978,
Advances in experimental medicine and biology,
O Bruserud, and
E Thorsby
July 1979,
Journal of immunology (Baltimore, Md. : 1950),
O Bruserud, and
E Thorsby
January 2013,
Zhurnal mikrobiologii, epidemiologii i immunobiologii,
O Bruserud, and
E Thorsby
November 2004,
The Journal of experimental medicine,
O Bruserud, and
E Thorsby
October 2005,
Tissue antigens,
O Bruserud, and
E Thorsby
June 1986,
Journal of clinical & laboratory immunology,
O Bruserud, and
E Thorsby
March 1984,
Arthritis and rheumatism,
